Clinical Chemistry

Papers
(The H4-Index of Clinical Chemistry is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl182
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology136
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?117
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests94
Clinical Chemistry's Invited Reviewers 202484
A-154 Reduction in Turnaround Time Achieved by Simplifying Hematology Middleware Rules78
A-170 CBC Results, flags and scattergram using BC 6800Plus Hematology Analyzer, for a case of Burkitt*s lymphoma in leukemic phase72
A-268 Evaluation of NAAT Recovery of Highly Pathogenic Avian Influenza A (H5N1) Clade 2.3.4.4b from Novel Proficiency Samples68
A-213 Highlights on Daily Internal Quality Controls for Improved Analytical Performance in Clinical Laboratory68
A-032 Evaluation of the Analytical Performance of Total Triiodothyronine (T3) and Total Thyroxine (T4) Assays on the Atellica CI Analyzer66
A-291 Rapidly Ruling Out Bacterial Infection: A Novel Host-Protein Assay for Patients with Suspected Respiratory Tract Infections in the Emergency Department66
A-181 Stability of urine in the BD Vacutainer® Plus Conical Urinalysis Preservative Tubes for Chemical and Microscopic Urinalysis62
A-172 Graphical contribution and CBC of BC-6800Plus hematology analyzer in a case of Myelodisplastic Syndrome related to Chemotherapy and Radiotherapy62
B-043 Clinical performance evaluation of the ABD PAD® as confirmatory testing of blood group60
A-312 Evaluation of the Analytical Performance of the Hepatitis B Surface Antigen and confirmatory assays on the Atellica CI Analyzer58
B-007 Activin A is a potential mediator of TGFß1-induced tubulointerstitial fibrosis51
B-088 Stability Assessment of Hormones and Tumor Markers: Can We Ensure High-Quality Patient Results Despite Operational Challenges?50
B-277 Validation of an Enzymatic Method for Quantification of Ethylene Glycol in Human Serum42
B-182 Evaluating Clinical Biochemical Diagnostic Approaches for Mitochondrial Diseases42
B-214 Migration of a Previously Validated Sequencing Workflow of 4,700 Genes Associated with Clinical Phenotypes to the MGI DNBSEQ-G400 Platform: High-Quality NGS Data with Elevated Concordance to Exp42
B-117 Inverse Association Between Regulatory T and B Cells with HLA antibodies and Donor-specific Antibodies in Kidney Transplantation40
A-050 The Role of Gut Microbial Metabolite Trimethylamine N-Oxide in Adrenal Cholesterol Homeostasis39
A-072 The Impact of Short and Prolonged Fasting on Routine Lab Tests39
B-278 Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening39
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication38
B-255 Engineered Reverse Transcriptases and Taq DNA Polymerases Deliver Robust Yield in the Presence of Clinically Relevant Inhibitors38
A-034 Prevention of Obesity and Metabolic Disorders Through a Gut Microbial Metabolite Derived from Polyphenol Supplementation in a High-Fat Diet38
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma37
B-314 Utility of he4 in differential diagnosis of pleural effusions37
A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report36
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows36
B-048 Proposal of a new monitoring algorythm for patients with a HIV positive result with the Elecsys HIV DUO test35
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-1935
B-080 Analytical Performance of ESPLINE HTLV-I/II34
0.1167209148407